bispecific antibodies | joshua richter, md | ash 2022
Published 1 year ago • 686 plays • Length 3:11
Download video MP4
Download video MP3
Similar videos
-
1:28
regeneron bispecific antibody targeting bcma update | joshua richter, md | ash 2021
-
2:18
t cell re-direction therapy | joshua richter, md | eha 2022
-
5:25
bispecific antibodies in myeloma | mark wildgust, phd | ash 2021
-
57:20
know your myeloma immunotherapy: bispecific antibodies with dr. cesar rodriguez
-
5:20
what are bispecifics in multiple myeloma? (for patients and caregivers) | dr. joshua richter
-
3:44
bispecific t cell engagers | noopur raje, md | ash 2022
-
14:00
what are bispecific antibodies?
-
57:58
how often should mrd testing occur during remission (and an mrd overview) with dr. joshua richter
-
5:29
updates on teclistamab, talquetamab, and carvykti | mark wildgust, phd | ash 2022
-
2:25
cevostamab in rrmm patients: camma 2 study results | joshua richter, md | eha 2024
-
1:53
istopmm study and early mgus and smm screening | joshua richter, md | ash 2021
-
0:55
what are bispecific antibodies?
-
28:25
the emerging world of bispecific antibodies | miami roundtable april 20, 2024
-
21:02
emerging bispecifics myeloma patients should know about | dr. joshua richter | the patient story
-
7:18
response rate on phase 1/2 trial regn5458 (bcmaxcd3 bispecific antibody) for rrmm patients
-
1:04:12
a promising future for treating multiple myeloma with bispecific antibodies
-
9:33
talquetamab | ajai chari, md | ash 2022
-
1:25
safety and efficacy of linvoseltamab for patients with r/r multiple myeloma
-
2:00
advancements in immunotherapy agents | hearn j. cho, md | ash 2022
Clip.africa.com - Privacy-policy